Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System

Abhinandan Singla, Gurpreet Singh, Gurnoor Kaur, Shivansh Luthra, Chirag Lodha, Mashaal S Malik, Sidra Kalsoom, Mohammed S Alo, Syed S Ali, Muhammad Zulqarnain

Open source

DOI: 10.7759/cureus.113379
Published: 2026-07-25
Container: Cureus
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7759/cureus.113379,
  title = {Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System},
  author = {Abhinandan Singla and Gurpreet Singh and Gurnoor Kaur and Shivansh Luthra and Chirag Lodha and Mashaal S Malik and Sidra Kalsoom and Mohammed S Alo and Syed S Ali and Muhammad Zulqarnain},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.113379},
  url = {https://doi.org/10.7759/cureus.113379}
}

RIS

TY  - JOUR
TI  - Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System
AU  - Abhinandan Singla
AU  - Gurpreet Singh
AU  - Gurnoor Kaur
AU  - Shivansh Luthra
AU  - Chirag Lodha
AU  - Mashaal S Malik
AU  - Sidra Kalsoom
AU  - Mohammed S Alo
AU  - Syed S Ali
AU  - Muhammad Zulqarnain
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.113379
UR  - https://doi.org/10.7759/cureus.113379
ER  -

APA

Singla, A., Singh, G., Kaur, G., Luthra, S., Lodha, C., Malik, M. S., Kalsoom, S., Alo, M. S., Ali, S. S., & Zulqarnain, M. (2026). Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System. Cureus. https://doi.org/10.7759/cureus.113379

Source records

crossref · retrieved 2026-09-24T23:38:16.512Z